Abbott Laboratories’ Best Segment Just Got Even Better: Is the Stock a Buy?
The company continues to flex its innovative muscles.
Mindfully Curated
The company continues to flex its innovative muscles.
This high-growth specialty retailer — up 12,600% since its IPO — is primed for only its second stock split in 31 years as a public company.